About
Reviews
Community
7th annual Tumor Models for Immuno-Oncology Summit
24
Jan
-
26
Jan
2023
When
San Francisco

USA
Where

With 2023 on track to see further growth in the immuno-oncology field, the availability of tools that offers drug developers & researchers advantages that weren’t available to them even a few years ago is increasing rapidly.

Why Attend

7th annual Tumor Models for Immuno-Oncology Summit

Network with experts, including Amgen, and Umoja Therapeutics to increase your clinical relevancy.

Grow

Discover how to improve in vivo preclinical toolbox to usher in the next generation of transgenic mouse models to advance therapies to the clinic faster.

Experience

Find solutions to combination therapy challenges including dosing, tumor heterogeneity, target engagement, & resistance through sessions.

Be inspired

Meet and network with selected CROs, model developers and academics to hear their latest platforms and form meaningful partnerships.

Similar Events

You May Like

event-img
(0)
21-26 September 2023
CANCER/EVOLUTION Summit 2023
event-img
(0)

21-26 September 2023

CANCER/EVOLUTION Summit 2023

The CANCER/EVOLUTION SUMMIT is the first virtual conference dedicated to metabolic, lifestyle, and nutritional therapies for cancer prevention and treatment. The summit will be held from September 21-26, 2023. The summit will feature presentations fr

Event Started

Virtual

Paid

Healthcare
event-img
(0)
25-25 September 2023
Emerging Immune Modulation Strategies
event-img
(0)

25-25 September 2023

Emerging Immune Modulation Strategies

The coronavirus pandemic ignited interest in learning more about immune responses to infections, their downstream effects, and how they can be modulated. It also gave rise to increased awareness of the role of immunity in diseases like cancer, neurod

Starts in 2 days

Hybrid

Paid

Washington, DC

Healthcare
event-img
(0)
25-25 September 2023
Strategies for Targeting Kinases
event-img
(0)

25-25 September 2023

Strategies for Targeting Kinases

There has been growing interest in targeting kinases such as JAK, TYK, IRAK, SIK, CDK, MEK, ERK, RTK, PLK, PI3K, ALK, MAPK, GSK, LRRK, and more for their role in neurodegeneration, inflammation, cancer, autoimmune, and other disorders. However, targe

Starts in 2 days

Hybrid

Paid

Washington, DC

Healthcare
event-img
(0)
25-28 September 2023
Discovery On Target 2023
event-img
(0)

25-28 September 2023

Discovery On Target 2023

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

Starts in 2 days

Hybrid

Paid

Boston

Healthcare
event-img
(0)
26-27 September 2023
Small Molecules Targeting RNA
event-img
(0)

26-27 September 2023

Small Molecules Targeting RNA

The coronavirus pandemic ignited interest in learning more about immune responses to infections, their downstream effects, and how they can be modulated. It also gave rise to increased awareness of the role of immunity in diseases like cancer, neurod

Starts in 3 days

Hybrid

Paid

Boston

Healthcare
event-img
(0)
26-27 September 2023
AI/ML-Enabled Drug Discovery – Part 1
event-img
(0)

26-27 September 2023

AI/ML-Enabled Drug Discovery – Part 1

Cambridge Healthtech Institute’s two-part conference on Artificial Intelligence (AI)/Machine Learning (ML)-Enabled Drug Discovery will highlight the increasing use of computational tools, AI modeling, algorithms, and data science for identifying nove

Starts in 3 days

Hybrid

Paid

Boston

Healthcare
event-img
(0)
26-27 September 2023
Proteomics-Driven Drug Discovery
event-img
(0)

26-27 September 2023

Proteomics-Driven Drug Discovery

While finding novel druggable targets and drug modalities for therapeutic intervention remains a top priority for the pharma/biotech industry, identifying and validating "good" targets and leads remains challenging. Cambridge Healthtech Institute’s c

Starts in 3 days

Hybrid

Paid

Boston

Healthcare
event-img
(0)
26-27 September 2023
GPCR-Based Drug Discovery
event-img
(0)

26-27 September 2023

GPCR-Based Drug Discovery

Cambridge Healthtech Institute's GPCR-Based Drug Discovery conference is now in its 18th year. G protein-coupled receptors (GPCRs), because of their central role in so many cellular processes, are still among the largest class of molecules modulated

Starts in 3 days

Hybrid

Paid

Boston

Healthcare
event-img
(0)
26-27 September 2023
Small Molecules for Cancer Targets – Part 1
event-img
(0)

26-27 September 2023

Small Molecules for Cancer Targets – Part 1

Small molecule-based therapeutic options against traditionally hard-to-drug intracellular oncology targets (like KRAS) are being discovered at a more rapid pace and a few have even reached the market in the past few years. Not only do small molecules

Starts in 3 days

Hybrid

Paid

Boston

Healthcare
event-img
(0)
26-27 September 2023
Antibodies Against Membrane Protein Targets – Part 1
event-img
(0)

26-27 September 2023

Antibodies Against Membrane Protein Targets – Part 1

As the industry increasingly shifts its attention to biologics, more attention is being paid to the prospect of developing biotherapeutics against membrane-bound targets. For these large target classes, biologics offer improved selectivity, an altern

Starts in 3 days

Hybrid

Paid

Boston

Healthcare

Event

Hanson Wade
0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

24 - 26 Jan 2023
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Ana Krtolica
Senior Vice President Preclinical Development
Anupurna Kaul
Postdoctoral Research Fellow
Dayson Moreira
Senior Scientist
Deepali Sawant
Principal Scientist
Dirk Brockstedt
Chief Scientific Officer
Elsa Quintana
Senior Director
Javier Pineda
Data Scientist
Jenna Frame
Senior Manager, Scientific Communications & Marketing
Liqin Liu
Senior Director
Won Lee
Associate Scientist
Shon Green
Senior Director - Translational Sciences
Tahmineh Safaie
Senior Associate Scientist

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Biocytogen

Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities.

Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities.

genOway

Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research.

Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research.

The Jackson Laboratory

Cancer. Diabetes. Alzheimer’s. Heart Disease. Parkinson’s. The Jackson Laboratory (JAX) leads the search to cure diseases rooted in our DNA.

Cancer. Diabetes. Alzheimer’s. Heart Disease. Parkinson’s. The Jackson Laboratory (JAX) leads the search to cure diseases rooted in our DNA.

Scientist.com

Scientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050.

Scientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050.

Crown Bioscience

Crown Bioscience, Inc. is a platform technology company providing drug discovery and development services in the areas of Oncology and Inflammation.

Crown Bioscience, Inc. is a platform technology company providing drug discovery and development services in the areas of Oncology and Inflammation.

Certis Oncology Solutions, Inc.

Certis began its journey in precision medicine, helping individual cancer patients and their oncologists determine--with certainty--the best available treatments for their unique cancers.

Certis began its journey in precision medicine, helping individual cancer patients and their oncologists determine--with certainty--the best available treatments for their unique cancers.

Kiyatec Inc.

Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins.

Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins.

Studylog Systems, Inc

We have six company Core Values – Trust, Loyalty, Respect for Others, Honesty, Integrity, and Commitment – that capture our philosophy towards our people and customers.

We have six company Core Values – Trust, Loyalty, Respect for Others, Honesty, Integrity, and Commitment – that capture our philosophy towards our people and customers.

Champions Oncology, Inc.

Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development.

Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development.

Organizer

All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.

Get emails from us

 
Thank you
Oops! Something went wrong